BrainStorm Cell Therapeutics
BCLI
#9833
Rank
S$1.59 M
Marketcap
$0.30
Share price
3.51%
Change (1 day)
9.79%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) Fails to deliver data

Key failure to deliver metrics for BrainStorm Cell Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BrainStorm Cell Therapeutics (BCLI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BrainStorm Cell Therapeutics (BCLI) - since 2014

Volume in USD (price x number of shares), data since 2014

BrainStorm Cell Therapeutics (BCLI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024S$1.43 M-89.59%
2023S$13.79 M642.46%
2022S$1.85 M-85.46%
2021S$12.78 M-82.4%
2020S$72.61 M2735.44%
2019S$2.56 M157.62%
2018S$0.99 M-51.31%
2017S$2.04 M321.02%
2016S$0.48 M-87.54%
2015S$3.89 M1886.66%
2014S$0.19 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
S$50.53 MS$0.22 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$12.93 MS$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
N/AS$15.56 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.56 MS$63.68 M๐Ÿ‡บ๐Ÿ‡ธ USA
N/AS$4.77 M๐Ÿ‡บ๐Ÿ‡ธ USA